PALISADES MEDICAL CENTER
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $2.2M
- Transactions
- 202
- Companies
- 12
- Average per transaction
- $11,036
Who reported the payments
| Pfizer | $1,689,113 |
| Regeneron | $241,801 |
| Amgen | $124,665 |
| Genentech, Inc. | $102,114 |
| Hoffmann-la Roche Limited | $24,077 |
| Epizyme, Inc. | $20,550 |
| Global Blood Therapeutics, Inc. | $10,750 |
| Stryker | $8,291 |
| Array Biopharma Inc | $5,091 |
| Bioventus LLC | $2,164 |
| Siemens Medical Solutions USA, Inc. | $379 |
| Samsung HME America, Inc. | $180 |